Article

Hyperopic LASIK results impressive at 6-month follow-up

Author(s):

Cheryl Guttman

Pekin, IL-Results from 6 months of follow-up in the Allegretto Wave (WaveLight Laser Technologie, Erlangen, Germany, and Lumenis) hyperopic LASIK clinical trial demonstrate excellent efficacy, safety, accuracy, and predictability, said William I. Bond, MD.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Related Content
Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
November 22nd 2024

Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases
November 22nd 2024

AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy
November 21st 2024

USC researchers receive $6 million CIRM grant to advance novel dry AMD therapy

Recent changes to cornea: Preferred Practice Patterns
November 21st 2024

Recent changes to cornea: Preferred Practice Patterns

© 2024 MJH Life Sciences

All rights reserved.